< Back to previous page
Researcher
Justine Vanhevel
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Sep 2016 → Today
Projects
1 - 1 of 1
- Vitamin D analogs in combination with palbociclib as treatment for triple-negative breast cancer – preclinical evaluation and pathway analysisFrom1 Sep 2016 → 31 Dec 2022Funding: FWO fellowships, BOF - Doctoral projects
Publications
1 - 5 of 5
- Vitamin D analogs in combination with palbociclib as treatment for breast cancer - preclinical evaluation and pathway analysis -(2022)
Authors: Justine Vanhevel, Mieke Verstuyf, Lieve Verlinden, Hans Wildiers
- The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D3 Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer(2022)
Authors: Justine Vanhevel, Lieve Verlinden, Shauni Loopmans, Stefanie Doms, Steve Stegen, Hans Wildiers, Mieke Verstuyf
- The role of vitamin D in breast cancer risk and progression(2022)
Authors: Justine Vanhevel, Lieve Verlinden, Stefanie Doms, Hans Wildiers, Mieke Verstuyf
Pages: R33 - R55 - Vdr expression in osteoclast precursors is not critical in bone homeostasis(2019)
Authors: Lieve Verlinden, Stefanie Doms, Justine Vanhevel, Geert Carmeliet, Mieke Verstuyf
- WY 1048, a 17-methyl 19-nor D-ring analog of vitamin D3, in combination with risedronate restores bone mass in a mouse model of postmenopausal osteoporosis(2019)
Authors: Stefanie Doms, Lieve Verlinden, Justine Vanhevel, Roger Bouillon, Mieke Verstuyf
Pages: 124 - 130